Physician profile
Anthony J Frey
NPI 1174565386
$1,759.76
in general payments reported to CMS, 2019-2025
26 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $63.06 · 2021: $154 · 2022: $326 · 2023: $219 · 2024: $601 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $265.33 | 2021-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.82 | 2022-2025 | Lifevest |
| Boston Scientific Corporation | $169.74 | 2020-2023 | Watchman Access System |
| Abbott Laboratories | $124.33 | 2019-2025 | Xience Skypoint |
| Pfizer INC. | $110.84 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $106.52 | 2021-2024 | Verquvo |
| Amgen INC. | $106.01 | 2021-2024 | Repatha |
| Scpharmaceuticals INC. | $97.11 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.49 | 2024 | Jardiance |
| Akcea Therapeutics, INC. | $81.57 | 2019 | |
| Irhythm Technologies, INC. | $67.76 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $41.87 | 2024 | |
| Sanofi-Aventis U.S. LLC | $34.64 | 2019 | |
| G Medical Diagnostic Services, INC. | $29.58 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.56 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $27.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $26.57 | 2019-2022 | |
| Cardinal Health 200 LLC | $25.36 | 2019 | |
| Cardiovascular Systems INC. | $22.01 | 2020 | |
| Atricure, INC. | $15.83 | 2024 | |
| Amarin Pharma, INC. | $15.67 | 2019 | |
| Medicomp INC | $15.15 | 2019 | |
| Kestra Medical Technology Services, INC. | $14.77 | 2023 | Assure Wcd |
| Amryt Pharma Holdings LTD | $14.20 | 2021 | |
| Medtronic Vascular, INC. | $13.20 | 2019 | |
| Bardy Diagnostics, INC. | $1.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.